Please note: 
In consideration of current staff shortage, the UAB MGL has implemented a limited business model to ensure that we maintain our high standard of testing quality. As a result, we are observing a moratorium on receiving CAL spot and/or neurofibroma biopsies for RNA-based NF1 testing. As a result, the following test codes are paused currently:
*Neurofibromas can still be tested using next generation sequencing but cannot be tested via RNA

Given the rapidly changing situation and the complexities of these testing approaches, the moratorium has been implemented to ensure that this testing is performed under the best circumstances possible. We are projecting this testing approach will be relaunched by January 2023. Please contact the MGL if you are considering this test or would like to discuss a specific case.

For more information regarding the Medical Genomics Laboratory holiday closures and sample receival availability, please see Holiday Closures


The Medical Genomics Laboratory (MGL) is a CAP-certified nonprofit clinical laboratory at the University of Alabama at Birmingham, offering comprehensive testing for common and rare genetic disorders.  The MGL specializes in testing for all forms of the neurofibromatoses including NF1, Legius syndrome (SPRED1 disorder), segmental NF, NF-Noonan, spinal NF, Watson syndrome, NF2, and schwannomatosis as well as the RASopathies, and tuberous sclerosis complex. 


UAB Medical Genomics Laboratory
720 20th St. S., Suite 330
Birmingham, AL 35294
Phone: 205.934.5562
Fax: 205.996.2929

Tell us how we are doing! Please complete our customer satisfaction survey and share your feedback! Please click here for survey